FDA

A landmark Supreme Court decision that reins in federal agencies’ authority is expected to hold dramatic consequences for the nation’s healthcare system, calling into question government rules on anything from consumer protections for patients to drug safety to nursing home care.

The treatments, both produced by Boston-area companies, join 32 other approved gene therapies and are approved to treat the disease in the United States.